CareLit Fachartikel
Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors
G. Janßen, U. Bode, H. Breu, B. Dohrn, V. Engelbrecht, U. Göbel · Klinische Pädiatrie · 2000 · Heft 04 · S. 189-195
Dokument
1068934
CareLit-ID
Jahr
2000
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Abstract: 19 children and adolescents with intracranial tumors received a palliative therapy with H 15® at a maximum dose of 126 mg/kg BW/day. All patients had previously been treated with conventional therapy. No side effects were observed during a median 9 months application. The recently reported antiedematous effect of H 15® was documented by MRI in one patient with a peritumoral edema, thus sparing steroid therapy with its typical side effects. Five/19 children reported an improvement of their general health status; this might be a psychological effect of hope for tumor response during palliative care. Thre…
Schlagworte
Brain tumor
boswellic acid
palliative care
H 15®
Hirntumor
Boswelliasäure
palliative Therapie
Klinische Pädiatrie
